Lorraine Webber is the UK Head of the Emerging Innovations Unit within AstraZeneca R&D. This is a small, externally-focussed R&D group primarily involved in drug re-purposing through pioneering ‘open innovation’ partnerships with a global network of external investigators, as well as internal drug repositioning.  Lorraine has a broad background in drug development and, prior to joining the Emerging Innovations team, led drug projects in early clinical development in a number of therapy areas including respiratory, dermatology and women’s health. Lorraine has also held roles in the global commercial organisations at AstraZeneca and Novartis. Lorraine gained her medical degree from Guy’s and St. Thomas’s Hospitals, University of London.lorai